Scotia Capital Inc. Amgen Inc Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Amgen Inc stock. As of the latest transaction made, Scotia Capital Inc. holds 51,224 shares of AMGN stock, worth $15.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

51,224

Previous 51,700 0.92%

Holding current value

$15.1 Million

Previous $16.2 Million 2.17%

% of portfolio

0.09%

Previous 0.1%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $147,264 - $160,592	-476 Reduced 0.92%	51,224 $16.5 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $1.62 Million - $1.97 Million	-6,177 Reduced 10.67%	51,700 $16.2 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $4.09 Million - $4.94 Million	15,211 Added 35.65%	57,877 $16.5 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $889,836 - $1 Million	3,480 Added 8.88%	42,666 $12.3 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $23,614 - $29,317	108 Added 0.28%	39,186 $10.5 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $321,833 - $380,561	-1,502 Reduced 3.7%	39,078 $8.68 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $108,153 - $131,820	-479 Reduced 1.17%	40,580 $9.81 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $1.11 Million - $1.41 Million	-4,847 Reduced 10.56%	41,059 $10.8 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $321,875 - $363,017	-1,434 Reduced 3.03%	45,906 $10.3 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $186,875 - $207,959	810 Added 1.74%	47,340 $11.5 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $543,131 - $600,845	2,477 Added 5.62%	46,530 $11.3 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $986,842 - $1.13 Million	4,962 Added 12.69%	44,053 $9.91 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $422,205 - $494,664	1,989 Added 5.36%	39,091 $8.31 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $334,252 - $370,829	1,431 Added 4.01%	37,102 $9.04 Million
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $2.35 Million - $2.74 Million	10,584 Added 42.19%	35,671 $8.88 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $189,116 - $225,203	874 Added 3.61%	25,087 $5.77 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $5.68 Million - $6.32 Million	24,213 New	24,213 $6.15 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $5.3 Million - $6.51 Million	-26,802 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $544,350 - $721,957	-2,987 Reduced 10.03%	26,802 $5.43 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $1.18 Million - $1.52 Million	-6,232 Reduced 17.3%	29,789 $7.18 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $1.15 Million - $1.38 Million	6,614 Added 22.49%	36,021 $6.97 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $3.03 Million - $3.56 Million	18,206 Added 162.54%	29,407 $5.42 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $598,317 - $674,435	3,308 Added 41.91%	11,201 $2.13 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $3,211 - $3,748	-18 Reduced 0.23%	7,893 $1.54 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $41,875 - $47,209	-226 Reduced 2.78%	7,911 $1.64 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $25,903 - $29,095	156 Added 1.95%	8,137 $1.38 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $2.23 Million - $2.61 Million	-13,180 Reduced 62.28%	7,981 $1.36 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $256,223 - $286,279	1,518 Added 7.73%	21,161 $3.68 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $55,038 - $62,839	329 Added 1.7%	19,643 $3.66 Million
Q2 2017 Aug 15, 2017	BUY	N/A	19,314	19,314 $3.33 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Amgen Inc Transaction History